Insider Transactions in Q1 2023 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
706
-0.59%
|
$7,060
$10.51 P/Share
|
|
Mar 20
2023
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
305
-0.65%
|
$3,355
$11.32 P/Share
|
|
Mar 20
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
238
-0.26%
|
$2,618
$11.32 P/Share
|
|
Mar 20
2023
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
390
-0.65%
|
$4,290
$11.32 P/Share
|
|
Mar 20
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
399
-0.45%
|
$4,389
$11.32 P/Share
|
|
Feb 22
2023
|
Nadim Ahmed President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
109,000
+47.87%
|
-
|
|
Feb 17
2023
|
Jeffrey Trigilio Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+34.71%
|
-
|
|
Feb 17
2023
|
Jacquelyn L Sumer Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+50.0%
|
-
|
|
Feb 17
2023
|
Corrine Savill Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+10.75%
|
-
|
|
Feb 17
2023
|
Jeffrey Alan Jones Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Feb 17
2023
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,500
+29.61%
|
-
|
|
Feb 17
2023
|
Patrick Baeuerle Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,500
+33.62%
|
-
|
|
Jan 19
2023
|
Bvf Partners L P > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
6,400,000
-85.16%
|
-
|